Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for June 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Novartis buys Manchester-based biotech and superbug drugs
Acquisition will assist company's expansion into hospital sector ..(more)

 Schering-Plough named in top 50 best places to work in UK
Employee survey propels company onto list at 39..(more)

 Study shows Inegy scores over its rival Crestor
Combination drug more effective than statin-only product..(more)

 Allergan chooses UK for research base
Move to Marlow brings 150 new jobs to area..(more)

 GPs launch scathing attack on health service reforms
Critics say December's PBC target is unattainable..(more)

 Galvus could offer hope to difficult-to-treat diabetes patients
Results show lowering of blood sugar levels and reduced weight gain..(more)

 Bayer clinches Schering purchase
Acquisition paves way for new German pharma giant..(more)

 Cancer vaccine continues to show encouraging results
TroVax to go ahead to phase III trial..(more)

 Blockbuster potential for diabetes vision drug
Arxxant first ever oral treament for retinopathy..(more)

 Combination pill cuts heart attacks
Data show Caduet substantially protects at-risk patients..(more)

 Humira gets go-ahead for the treatment of ankylosing spondylitis
Abbott drug set to chase market leaders ..(more)

 Half of COPD patients misdiagnosed, says survey
Failure to treat allows condition to progress unchecked..(more)

 Relief for campaigners as NICE approves Herceptin
But PCTs face tough financing decisions..(more)

 True scale of NHS deficits 'masked' says think tank
But government claims figures better than predicted..(more)

 China upholds Viagra patent
People's Court decision aims to hold back generic firms..(more)

 Avastin filed for advanced breast cancer
Submission should further boost sales of blockbuster drug..(more)

 Practice 'clusters' urged to lead next phase of NHS revolution
Hopes that practice-based commissioning is the way forward..(more)

 OTC regulations to be streamlined
'Self-certification' scheme for minor label changes..(more)

 European agreement to improve children's medicines
New measures to make paediatric drugs safer..(more)

 Exelon is first drug for Parkinson's disease dementia
Up to 48,000 Parkinson's patients could benefit..(more)

 Phytopharm looks for licensing partner for Alzheimer drug
Company claims Cogane is a breakthrough treatment..(more)

 Pfizer's insomnia treatment hit by ruling
High-dose version of Indiplon refused approval..(more)

 Pharmacists given new guidance on counterfeit medicines
Awareness-raising initiative warns on danger of fake drugs..(more)

 NICE set to recommend new 'gold standard' treatments for early-stage breast cancer
Three new drugs expected to replace tamoxifen..(more)

 Acomplia poised for approval as NHS focuses on fighting fat
Weight loss drug could peak at more than $1 billion..(more)

 GSK investors opt for anonymity in face of animal extremist threat
Administrative loophole protects investors' identities..(more)

 PCT mergers bring end to uncertainty
Restructuring and reforms begin for patient-centred NHS..(more)

 First private contractors to provide GP services
Care UK to open new surgery and walk-in centre..(more)

 Roundhouse joins Affiniti marketing communications group
with further acquisitions planned for 2006..(more)

 Outrage over NICE verdict on Alzheimer's drugs
Use of AChE inhibitors to be restricted..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.